
04/19/2025
Dupilumab's approval marks the first new, targeted therapy for CSU in more than a decade and is the 7th indication for a disease with underlying type 2 inflammation.
We are a medical practice specializing in the treatment of allergies, asthma and immune dysfunction.
20950 N. Tatum Boulevard Ste 270
Phoenix, AZ
85050
Monday | 9am - 5:30pm |
Tuesday | 9am - 6:30pm |
Thursday | 9am - 6:30pm |
Friday | 9am - 5:30pm |
Be the first to know and let us send you an email when Desert Ridge Allergy Associates posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Desert Ridge Allergy Associates: